Literature DB >> 11416160

Expression and functional significance of VE-cadherin in aggressive human melanoma cells: role in vasculogenic mimicry.

M J Hendrix1, E A Seftor, P S Meltzer, L M Gardner, A R Hess, D A Kirschmann, G C Schatteman, R E Seftor.   

Abstract

We recently have introduced the term vasculogenic mimicry to describe the unique ability of aggressive melanoma tumor cells to form tubular structures and patterned networks in three-dimensional culture, which "mimics" embryonic vasculogenic networks formed by differentiating endothelial cells. In the current study, we address the biological significance of several endothelial-associated molecules (revealed by microarray analysis) with respect to expression and function in highly aggressive and poorly aggressive human cutaneous melanoma cell lines (established from the same patient). In a comparative analysis, CD31 was not expressed by any of the melanoma cell lines, whereas TIE-1 (tyrosine kinase with Ig and epidermal growth factor homology domains-1) was strongly expressed in the highly aggressive tumor cells with a low level of expression in one of the poorly aggressive cell lines. Vascular endothelial (VE)-cadherin was exclusively expressed by highly aggressive melanoma cells and was undetectable in the poorly aggressive tumor cells, suggesting the possibility of a vasculogenic switch. Down-regulation of VE-cadherin expression in the aggressive melanoma cells abrogated their ability to form vasculogenic networks and directly tested the hypothesis that VE-cadherin is critical in melanoma vasculogenic mimicry. These results highlight the plasticity of aggressive melanoma cells and call into question their possible genetic reversion to an embryonic phenotype. This finding could pose a significant clinical challenge in targeting tumor cells that may masquerade as circulating endothelial cells or other embryonic-like stem cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11416160      PMCID: PMC35460          DOI: 10.1073/pnas.131209798

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

Review 1.  Mechanisms of angiogenesis and arteriogenesis.

Authors:  P Carmeliet
Journal:  Nat Med       Date:  2000-04       Impact factor: 53.440

2.  Developmental biology. One cell, two fates.

Authors:  P Carmeliet
Journal:  Nature       Date:  2000-11-02       Impact factor: 49.962

Review 3.  Vascular-specific growth factors and blood vessel formation.

Authors:  G D Yancopoulos; S Davis; N W Gale; J S Rudge; S J Wiegand; J Holash
Journal:  Nature       Date:  2000-09-14       Impact factor: 49.962

Review 4.  Tumor sinuses- vascular channels.

Authors:  J Tímár; J Tóth
Journal:  Pathol Oncol Res       Date:  2000       Impact factor: 3.201

5.  Vascular-endothelial cadherin (CD144)- but not PECAM-1 (CD31)-based cell-to-cell contacts convey the maintenance of a quiescent endothelial monolayer.

Authors:  T Halama; G Staffler; S Hoch; H Stockinger; K Wolff; P Petzelbauer
Journal:  Int Arch Allergy Immunol       Date:  1999-11       Impact factor: 2.749

6.  Angiomatoid melanoma: a novel pattern of differentiation in invasive periocular desmoplastic malignant melanoma.

Authors:  J A Baron; F Monzon; N Galaria; G F Murphy
Journal:  Hum Pathol       Date:  2000-12       Impact factor: 3.466

7.  Monoclonal antibody to vascular endothelial-cadherin is a potent inhibitor of angiogenesis, tumor growth, and metastasis.

Authors:  F Liao; Y Li; W O'Connor; L Zanetta; R Bassi; A Santiago; J Overholser; A Hooper; P Mignatti; E Dejana; D J Hicklin; P Bohlen
Journal:  Cancer Res       Date:  2000-12-15       Impact factor: 12.701

8.  Blood-derived angioblasts accelerate blood-flow restoration in diabetic mice.

Authors:  G C Schatteman; H D Hanlon; C Jiao; S G Dodds; B A Christy
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

9.  Molecular classification of cutaneous malignant melanoma by gene expression profiling.

Authors:  M Bittner; P Meltzer; Y Chen; Y Jiang; E Seftor; M Hendrix; M Radmacher; R Simon; Z Yakhini; A Ben-Dor; N Sampas; E Dougherty; E Wang; F Marincola; C Gooden; J Lueders; A Glatfelter; P Pollock; J Carpten; E Gillanders; D Leja; K Dietrich; C Beaudry; M Berens; D Alberts; V Sondak
Journal:  Nature       Date:  2000-08-03       Impact factor: 49.962

10.  Mosaic blood vessels in tumors: frequency of cancer cells in contact with flowing blood.

Authors:  Y S Chang; E di Tomaso; D M McDonald; R Jones; R K Jain; L L Munn
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

View more
  156 in total

1.  New approaches to the biology of melanoma: a workshop of the National Institutes of Health Pathology B Study Section.

Authors:  Meenhard Herlyn; Martin Padarathsingh; Lynda Chin; Mary Hendrix; Dorothea Becker; Mark Nelson; Yves DeClerck; James McCarthy; Suresh Mohla
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

Review 2.  Involvement of members of the cadherin superfamily in cancer.

Authors:  Geert Berx; Frans van Roy
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-09-23       Impact factor: 10.005

3.  VEGF increases engraftment of bone marrow-derived endothelial progenitor cells (EPCs) into vasculature of newborn murine recipients.

Authors:  Pampee P Young; A Alex Hofling; Mark S Sands
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-23       Impact factor: 11.205

Review 4.  Differential regulation of EphA2 in normal and malignant cells.

Authors:  Jennifer Walker-Daniels; Angela R Hess; Mary J C Hendrix; Michael S Kinch
Journal:  Am J Pathol       Date:  2003-04       Impact factor: 4.307

5.  CD133+ niches and single cells in glioblastoma have different phenotypes.

Authors:  Karina Christensen; Henrik Daa Schrøder; Bjarne Winther Kristensen
Journal:  J Neurooncol       Date:  2010-12-24       Impact factor: 4.130

Review 6.  Involvement of non-vascular stem cells in blood vessel formation.

Authors:  Nobuyuki Takakura
Journal:  Int J Hematol       Date:  2012-02-04       Impact factor: 2.490

7.  Ras and Rho GTPases on the move: The RasGRF connection.

Authors:  Piero Crespo; Fernando Calvo; Victoria Sanz-Moreno
Journal:  Bioarchitecture       Date:  2011-07-01

Review 8.  CD133-targeted niche-dependent therapy in cancer: a multipronged approach.

Authors:  Anthony B Mak; Caroline Schnegg; Chiou-Yan Lai; Subrata Ghosh; Moon Hee Yang; Jason Moffat; Mei-Yu Hsu
Journal:  Am J Pathol       Date:  2014-02-28       Impact factor: 4.307

9.  Comparative promoter analysis allows de novo identification of specialized cell junction-associated proteins.

Authors:  Clemens D Cohen; Andreas Klingenhoff; Anissa Boucherot; Almut Nitsche; Anna Henger; Bodo Brunner; Holger Schmid; Monika Merkle; Moin A Saleem; Klaus-Peter Koller; Thomas Werner; Hermann-Josef Gröne; Peter J Nelson; Matthias Kretzler
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-31       Impact factor: 11.205

Review 10.  The role of altered cell-cell communication in melanoma progression.

Authors:  Nikolas K Haass; Keiran S M Smalley; Meenhard Herlyn
Journal:  J Mol Histol       Date:  2004-03       Impact factor: 2.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.